A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.


The effects of lidoflazine on exercise tolerance have been tested during a double-blind cross-over trial in 14 male post-infarction patients with a median age of 47 years (range 24-85). Each treatment phase lasted three months. Lidoflazine dosage was one 60 mg tablet t.i.d. At rest, significant decreases in diastolic blood pressure (DBP) and heart rate (HR… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.